Black Bird Biotech, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BBBT research report →
Price Chart
About the company
Black Bird Biotech Inc. operates within the biotechnology sector, offering a diverse array of products. A key offering is MiteXstream, a unique plant-derived biopesticide manufactured and distributed by the company, specifically formulated to eradicate spider mites.
- CEO
- Nelson Grist
- IPO
- 2009
- Employees
- 4
- HQ
- Argyle, TX, US
Get TickerSpark's AI analysis on BBBT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $98.41K
- P/E
- -0.02
- PEG
- -0.00
- P/S
- 1.19
- P/B
- -0.05
- EV/EBITDA
- -0.60
- Div Yield
- 0.00%
- Gross Margin
- -67.71%
- Op Margin
- -1560.42%
- Net Margin
- -2009.09%
- ROE
- -16554.55%
- ROIC
- -6571.45%
Latest fiscal year · YoY change
- Revenue
- $82.56K-21.0%
- Gross Profit
- $-55,906-385.4%
- Op Income
- $-1,288,333
- Net Income
- $-1,658,766+8.4%
- EPS
- $-0.01+46.2%
- OCF Growth
- -4.0%
- FCF Growth
- -3.5%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 1.87
- RSI (14)
- 52
- Avg Volume
- 1.82M
No earnings-call transcripts are available for BBBT yet.
- Free Float
- 99.9%
- Shares Outstanding
- 984.05M
- Float Shares
- 983.07M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 15, 09 | Collins Jeffrey A | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our BBBT coverage
Recent articles, reports, and earnings notes.
No research on BBBT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate BBBT report →Black Bird Biotech Announces New CEO; Provides Commentary on Refreshed Path
globenewswire.com · Apr 16
Black Bird Biotech Launches MiteXstream(TM) Online Store for Direct Sales to Commercial and Home Users
accesswire.com · Oct 7
Black Bird Biotech Retires Three Separate Convertible Notes with Cash Repayments
accesswire.com · Oct 5
Black Bird Biotech Announces Important Wide-Ranging Field Tests of its Disruptive MiteXstreamTM Biopesticide by A Second International Agri-Chemical Distributor Based in the Middle East
accesswire.com · Sep 28
Black Bird Biotech Seeks Approval in All Remaining States, to Open Up Entire US Market, Including the Projected $45 Billion Cannabis Industry, for its Disruptive Plant-Based MiteXstreamTM Biopesticide Sales Efforts
accesswire.com · Sep 21
Black Bird Biotech Announces First Sales of Disruptive Plant-Based MiteXstreamTM Biopesticide, Prepares for Fourth Quarter Marketing Push Within Cannabis Industry
accesswire.com · Sep 14
Black Bird Biotech to Seek EPA Approval of MiteXstream(TM) Ready-to-Use Formulation
accesswire.com · Jul 21
Black Bird Biotech Announces MiteXstream Summer Field Testing on Mite-Plagued Vegetable Crops in Israel by International Agri-Chem Company
accesswire.com · Jul 19
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.